Novan (NOVN) : 10-month performance

• The company will host a conference call next Wednesday, August 2, to update investors on its activities and progress.
• Several months ago, it reported positive results from a mid-stage study of SB208, a topical treatment for certain fungal infections. Shares plummeted in January after lead product candidate SB204 showed less-than-expected results in a late-stage acne study.
• Previously: Novan reports positive topline results with SB208 in Phase 2 trial; shares ahead 50% premarket (April 12)
• Previously: Novan's lead product product shows mixed results in pivotal studies; shares plummet 76% (Jan. 27)

Description

Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs). The Company's formulation science enables it to further tune the release of nitric oxide when applied to the skin by using the combinations of inactive ingredients. It is developing SB204 for the treatment of acne vulgaris in Phase III. The Company is developing its product candidate, SB206, for the treatment of external genital and perianal warts in Phase II. It is developing SB208, an investigational topical anti-fungal for the treatment of fungal infections of the skin and nails. It is developing SB204 for the treatment of inflammatory skin diseases. Its pipeline also includes SB414, a topical cream product candidate.

Address

4105 Hopson Rd
MORRISVILLE, NC 27560-9018
United States 

Website 

http://www.novantherapeutics.com

Key stats and ratios

	Q1 (Mar '17)	2016
Net profit margin	-11607.00%	-
Operating margin	-11377.00%	-
EBITD margin	-	-
Return on average assets	-92.15%	-116.73%
Return on average equity	-179.76%	-
Employees	62

Blue Apron (APRN) : 1-month performance

HA

Alteryx (AYX) : 4-month performance

Redfin (RDFN) started trading on the Nasdaq on 28 July 2017

• Seattle-based, 11-year-old online brokerage company sold its shares for $15, valuing the company at roughly $1.2 billion.
• On its trading debut, the stock closed up nearly 45%, to $20.70,  giving Redfin a market capitalization of about $1.73 billion.
• The firm had just a 0.58% share of U.S. existing home sales by dollar volume in the first quarter this year, according to its IPO filing.  Coldwell Banker Residential Brokerage, had a 6.1% share in the 12 months ending June 30.
• The company is now in more than 80 markets across the U.S., including Southern California, Seattle and San Francisco.

Redfin’s website and app also let users search a map for homes on the market, regardless of the listing brokerage, and they provide an estimate of what homes are worth, even if they are not for sale — the same features of popular website Zillow.

But unlike Zillow, which is not a brokerage, Redfin has its own agents. And the company even does

that differently than most brokerages, employing them as salaried employees, rather than as independent contractors paid through sales commissions.

Redfin says its online tools mean it can spend less on marketing than typical brokerages do to find customers. And that allows it to demand less in commissions, resulting in savings for clients of $3,500 on average last year.

Key stats and ratios

	Q1 (Mar '17)	2016
Net profit margin	-46.88%	-8.43%
Operating margin	-46.97%	-8.53%
EBITD margin	-	-6.17%
Return on average assets	-89.92%	-17.43%
Return on average equity	-	-
Employees	2,164

Address

3055 112th Ave NE Ste 100
BELLEVUE, WA 98004
United States 

Website 

https://www.redfin.com

Description

Redfin Corporation is a United States-based real estate broker company. The Company provides real estate search and brokerage services. The customer can search for homes by neighborhood, city or MLS number, or can refine results using detailed parameters, such as price and number of beds or baths. The Company serves home buyers and sellers. Redfin Builder Services is its sales platform designed specifically for home builders and condominium developers. Redfin Builder Services support product analysis, digital marketing, media, listing management and sales, pricing, and reporting. The customer can search homes for sale in Austin, Atlanta, Baltimore, Boston, Charlotte, Chicago, Dallas, Denver, Fort Lauderdale, Houston, Lake Tahoe, Las Vegas, Los Angeles, Miami, New York, Philadelphia, Phoenix, Portland, OR, Raleigh, San Antonio, San Diego, San Francisco, Sacramento, San Jose, San Luis Obispo, Santa Barbara, Seattle, Washington, and West Palm Beach.

Apollo Global Preparing IPO for 2017 ADT

• Offering could value home-security company at more than $15 billion
• Apollo purchased Protection 1 and ASG Security in 2015, combined them, and then used that company to acquire ADT for about $7B last year.
• ADT did an $800M dividend recap in February.

Ancestry.com aiming for 2017 IPO

• Ancestry.com is close to hiring banks to lead an initial public offering of the company this year, Bloomberg reports.
• Company is said to work with Morgan Stanley, Goldman, JPMorgan
• Permira, Spectrum took genealogy company private in 2012 LBO

The private equity-backed company is working with Morgan Stanley, Goldman Sachs and JPMorgan for the listing, which could give it a market value of more than $3B.

Ancestry.com already generates more than $1B in revenue and has a growth rate of about 25%.  It’s grown rapidly through new ventures such as its DNA testing kits.

PetIQ (PETQ) started trading on the Nasdaq on 21 July 2017

PetIQ, which distributes pet medications, sold 6,250,000 million shares at $16 a share to raise $100 million. The company posted net sales of $200.2 million in 2016 on top of a loss of $3.4 million. However, in the three months ended in March of this year, the company swung to a profit, with net income of $4.3 million on sales of $67 million. It granted underwriters a 30-day option to sell an additional 937,500 shares. Jefferies and William Blair were the lead underwriters on the offering.

PetIQ, Inc. (PETQ) a manufacturer and distributor of pet medications.  The company sells medication in three categories.

1. Prescription medications for heartworm prevention, arthritis and heart disease.
2. Over-the-counter medications for flea and tick prevention.
3. Health and wellness products, which include vitamins, treats, hygiene products and nutritional supplements.

The company has its products in 40,000 retail pharmacies. It also has supply deals with Wal-Mart (WMT), Sam’s Club, Costco (COST), PetSmart (PETM), Petco (PETC), Kroger (KR), Target (TGT) and BJ’s Wholesale.

Americans spent $81.4 billion on pet products and services in 2016, compared to $28.5 billion in 2001.  Sales of pet medications alone are estimated to have grown to $7.4 billion in 2016 from $5.8 billion in 2011 and are expected to reach $8.9 billion by 2019, according to PetIQ's Form S-1 filed with the Securities and Exchange Commission.

Scott Adcock, left, cofounder and president of PetIQ, an Eagle pet-medications maker, and Cord Christensen, right, cofounder and CEO

PetIQ employees and some of their family members attended a ceremony Friday, July 21, 2017, at Nasdaq’s headquarters in New York City to mark the initial offering of PetIQ stock to the public. 

PetIQ CEO Cord Christensen

PetIQ products

PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.

Website:  

https://petiq.com

Address

Suite 120 500 E. Shore Drive 83616
Eagle, ID
United States

Alibaba (BABA) reported earnings Thur 17 Aug 2017 (b/o)

• #15  on 8/16 (just before earnings); vol. 21.3 M
• #15 8/14 - 8/16

** charts before earnings **

 

** charts after earnings **

Alibaba beats by $0.24, beats on revs

• Reports Q1 (Jun) earnings of $1.17 per share, excluding non-recurring items, $0.24 better thanthe Capital IQ Consensus of $0.93; revenue +56% to $7.40 bln vs. $7.16 bln consensus.
  • Revenue from core commerce increased 58% year-over-year to RMB43,027 million (US$6,347 million).
  • Revenue from cloud computing increased 96% year-over-year to RMB2,431 million (US$359 million).
  • Revenue from digital media and entertainment increased 30% year-over-year to RMB4,081 million (US$602 million).
  • Revenue from innovation initiatives and others increased 21% year-over-year to RMB645 million (US$95 million).
  • Annual active consumers (formerly annual active buyers) on China retail marketplaces reached 466 million, an increase of 12 million from the 12-month period ended March 31, 2017.
  • Mobile MAUs on China retail marketplaces reached 529 million in June, an increase of 22 million over March 2017.
  • The number of paying customers of cloud computing business grew to 1,011,000 from 874,000 in the previous quarter. Operating loss from cloud computing was RMB532 million (US$78 million) and adjusted EBITA loss was RMB103 million (US$15 million).
  • "The significant growth in customer management revenue represents the differentiated business value we provide to our customers," said Maggie Wu, Chief Financial Officer of Alibaba Group. "It is our intention to continue investing in long-term growth opportunities, some of which are already delivering significant value to customers and investors."

Roku expects to launch IPO before year-end

Roku Inc., which makes streaming-media devices and software, is preparing an initial public offering it expects to launch before year-end, according to people familiar with the company’s plans. The Los Gatos, Calif., company recently hired Morgan Stanley , Citigroup Inc. and Allen & Co. as underwriters on the IPO, these people said. The company could file confidentially in the next few weeks, one of the people said.

Five Point Holdings (FPH) : 2-month performance

 

=Yum China Holdings (YUMC) reported earnings on Wed 5 July 2017 (a/h)

July 6 (Reuters) - Yum China Holdings Inc, the operator of KFC, Pizza Hut and Taco Bell in the world's second-largest economy, posted quarterly sales slightly below estimates, dragged down by sluggish growth at Pizza Hut amid a turnaround drive.

The firm, which spun off from Yum Brands Inc late last year, said same-store sales rose 3 percent in the second quarter of 2017, driven by a 4 percent jump at fried chicken chain KFC. Pizza Hut's same-store sales were flat.

Yum, China's biggest fast food chain with over 7,685 outlets, has been looking to rev up growth in the market which has slowed since 2012, hit by food safety scares, changing consumer tastes and a wider economic slowdown.

The Pizza Hut division, which has been off-setting stronger growth at KFC since before Yum China's listing, fell short of analyst estimates of a 1.5 percent same-store sales rise, according to research firm Consensus Metrix.

Joey Wat, Yum China's president and chief operating officer, told analysts after the results that the pizza unit had been struggling and there were "quite a few key aspects of the fundamentals of the business that we have to fix".

"There is a still a long way to go to turn around Pizza Hut and we are working diligently to get things done," she said.

KFC's growth was stronger, helping push overall same-store sales above the average analyst estimate of a rise of 2.4 percent.

Shares in the company eased, however, on the concerns over Pizza Hut.

Yum China has been trying to turn around the unit by simplifying its menu, as well as making a push on mobile payments and delivery. It recently bought a controlling stake in local food-delivery service Daojia.

The fast food chain's net income rose to $107 million, or 27 cents per share, in the quarter, from $77 million, or 21 cents per share, a year earlier, which management said was helped by an industry wide tax reform. Margins also widened.

Total revenue fell 0.4 percent to $1.59 billion, slightly missing the average analyst estimate of $1.60 billion, according to Thomson Reuters I/B/E/S.

Bankrate (RATE) to be acquired by Red Ventures for $14.00 per share

    

Bankrate was acquired by Red Ventures for $1.24 billion in November, 2017.

• In September 2018, the former chief financial officer Edward J. DiMaria was found guilty of committing accounting and securities fraud which led to over $25 million in shareholder losses. DiMaria was sentenced to 10 years in prison, and ordered to pay $21,234,214 in restitution. Former vice president of finance Hyunjin Lerner also pleaded guilty for his role in the conspiracy and was sentenced to 5 years in prison.

  

Red Ventures LLC, a privately-owned marketing company, said Monday it has agreed to buy personal finance website operator Bankrate Inc. in a $1.24 billion all-cash deal, as it seeks to expand its presence in the financial-services industry.

Bankrate shareholders will receive $14 per share, representing a 9 percent premium to the stock's Friday closing.

The deal has an enterprise value of $1.4 billion.